RNA Therapeutics
Part of Healthcare - Genomics & Precision Medicine
 ALNY | Alnylam Pharmaceuticals, Inc. | $29.4b | $225.25 | +1.8% | 1.2M |
 ARWR | Arrowhead Research Corporation | $9.1b | $61.00 | -1.3% | 1.4M |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | $7.2b | $43.76 | +1.2% | 1.9M |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | $0.7b | $3.50 | -6.1% | 3.1M |
 CAMP | CAMP4 Therapeutics Corporation Common Stock | $251.0m | $3.88 | -1.0% | 1.2M |
 PRQR | ProQR Therapeutics N.V. Ordinary Shares | $230.7m | $1.64 | -0.9% | 492.4K |
 RNAC | Cartesian Therapeutics, Inc. Common Stock | $222.7m | $6.75 | -5.2% | 161.1K |
 RNA | Atrium Therapeutics, Inc. Common Stock | $134.1m | $7.99 | +0.3% | 216.1K |
 PHIO | Phio Pharmaceuticals Corp. Common Stock | $11.4m | $0.99 | +0.9% | 130.7K |
 XCUR | Exicure, Inc. Common Stock | $7.5m | $1.09 | 0.0% | 7.3K |